ClinicalTrials.gg
RecruitingNCT07930221Updated Nov 12, 2026

The Effects of Yoga Practice on Exercise Capacity, Arterial Stiffness, Respiratory Function, Peripheral Muscle Strength, Posture and Quality of Life in Children With Cystic Fibrosis

An interventional study of aerobic exercises + yoga and aerobic exercises in Cystic Fibrosis (CF), sponsored by Hacettepe University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 8 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Hacettepe University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Jul 2025, registered Nov 2026).
  • Started Jul 2025; still recruiting 1 year 4 months later.
Updated Nov 12, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
8 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 16 studies in Cystic Fibrosis by Hacettepe University — 2 open to participants now, 2 under way, none of them phase 3. Cystic Fibrosis · Hacettepe University.

Started
2025
the only one that year
No phase
4 of 16
1 open now
Registered
16th of 16
by date

Among the 16 studies in Cystic Fibrosis by Hacettepe University, this one is the only one that started in 2025, is one of 4 with no phase, and was the 16th registered.

Cystic Fibrosis

1,621 studies on the registry are indexed under Cystic Fibrosis; 201 are open to participants now.

Browse Cystic Fibrosis studies →

Open to participants now

2 of the 16 studies in Cystic Fibrosis by Hacettepe University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 156 Cystic Fibrosis studies recruiting now, 95 (61%) set no upper age limit and 45 (29%) stop at 75 or younger; 86 take children under 18; 41 take healthy volunteers.

This study: 8 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Cystic Fibrosis by Hacettepe University, or all of them as a file.
02

Study summary

The aim of this study is to investigate the effects of exercise training applied through telerehabilitation on exercise capacity, peripheral and respiratory muscle strength, arterial stiffness, posture and quality of life in children with cystic fibrosis.

Read the detailed description

The most common problems in patients with cystic fibrosis (CF) are increased bronchial secretions, reduced exercise tolerance and shortness of breath.

Exercise capacity is limited due to muscle dysfunction, inflammation and progressive respiratory disease. Cardiovascular complications are one of the long-term complications of CF. Increased arterial stiffness is an indicator of elevated cardiovascular risk. It has been shown that patients with CF have increased arterial stiffness compared to their healthy peers.

Exercise training has a positive effect on exercise capacity, respiratory function and quality of life in patients with CF. Studies have shown that exercise training applied using the telerehabilitation method increases exercise capacity and improves peripheral muscle function in patients with CF. Peripheral muscle function, functional capacity, arterial stiffness and posture have been assessed in patients with CF. Furthermore, studies have been performed on patients with CF involving exercise training via telerehabilitation.In addition, various studies have shown that yoga and aerobic exercise training have positive effects on arterial stiffness. Although there are only a few studies involving patients with CF who practise yoga, no study has been found that assesses the effects of yoga practise via telerehabilitation on exercise capacity, peripheral and respiratory muscle function, and arterial stiffness.The purpose of this study is to examine the effects of exercise training using telerehabilitation on exercise capacity, peripheral and respiratory muscle strength, arterial stiffness, posture and quality of life in children with CF.

Children were randomly assigned to three groups: The first group will receive online aerobic exercise training and yoga sessions. The second group will receive only aerobic exercise training.The third group will be informed about the importance of physical activity and will be given recommendations for physical activity. Participants' respiratory function, exercise capacity, arterial stiffness parameters, peripheral muscle function, posture and quality of life questionnaire will be evaluated initially and following an 8-week exercise programme.

03

Conditions studied

  • Cystic Fibrosis (CF)

Keywords

  • exercise
  • yoga
04

Who can participate

Ages eligible
8 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 8-18 years with a diagnosis of cystic fibrosis (CF)
  • Access to online exercise training
  • Percent predicted of forced expiratory volume at one second () > 40% in pulmonary function test

Exclusion criteria

Exclusion Criteria:

  • Being diagnosed with acute pulmonary exacerbation at the time of study and /or within the last month.
  • Being physically or perceptually competent to exercise
  • Patients with allergic bronchopulmonary aspergillosis who were treated with systemic therapy
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

FEV1

From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Combined Group

    aerobic exercise training and yoga sessions in patients with cystic fibrosis

    Other: aerobic exercises + yoga

  • Experimental
    aerobic group

    only aerobic exercises in patients with cystic fibrosis

    Other: aerobic exercises

  • Experimental
    control group

    physical activity recommendations in patients with cystic fibrosis

    Other: Physical activity recommendations

Interventions

  • Otheraerobic exercises + yoga

    Patients will be performed online in groups of 3-4 participants supervised aerobic exercises and yoga sessions. Aerobic exercises will be applied for 8 weeks, for 30-45 minutes, at 65-75% of the maximum heart rate, 3 days a week, on the days when yoga sessions are not performed. The yoga sessions will consist of 30-40-minute sessions, with three sessions per week for eight weeks. The yoga sessions will consist of three core components - asana (postures), pranayama (breathing) and meditation (focus).

  • Otheraerobic exercises

    Patients will be performed online in groups of 3-4 participants supervised only aerobic exercises Aerobic exercises will be applied for 8 weeks, for 30-45 minutes, at 65-75% of the maximum heart rate, 3 days a week.

  • OtherPhysical activity recommendations

    Patients will be informed of the benefits of physical activity and appropriate physical activity recommendations will be provided.

06

What researchers measure

Primary outcomes

  1. six minute walk test

    the distance reached in the six-minute walk test

    Time frame: before the exercise training

  2. six minute walk test

    the distance reached in the six-minute walk test

    Time frame: eigth week

Secondary outcomes

  1. Arterial stiffness

    Arterial stiffness will be assessed non-invasively using the Mobil-O-GRAPH (I.E.M., Stolberg, Germany).

    Time frame: before the exercise training

  2. Arterial stiffness

    Arterial stiffness will be assessed non-invasively using the Mobil-O-GRAPH (I.E.M., Stolberg, Germany).

    Time frame: eight week

  3. Respiratory muscle strength

    Respiratory muscle strength will be evaluated using mouth pressure device

    Time frame: before the exercise training

  4. Respiratory muscle strength

    Respiratory muscle strength will be evaluated using mouth pressure device

    Time frame: eight week

  5. respiratory muscle endurance

    Respiratory muscle endurance will be assessed using constant load test

    Time frame: before the exercise training

  6. respiratory muscle endurance

    Respiratory muscle endurance will be assessed using constant load test

    Time frame: eight week

  7. Pulmonary functions-FVC

    Forced vital capacity (FVC)

    Time frame: before the exercise training

  8. Pulmonary functions-FVC

    Forced vital capacity (FVC)

    Time frame: eight week

  9. Pulmonary functions-FEV1

    Forced expiratory volume in the first second (FEV1)

    Time frame: before the exercise training

  10. Pulmonary functions-FEV1

    Forced expiratory volume in the first second (FEV1)

    Time frame: eigth week

  11. Pulmonary functions-FEV1/FVC

    FEV1/ FVC

    Time frame: before the exercise training

  12. Pulmonary functions-FEV1/FVC

    FEV1/ FVC

    Time frame: eight week

  13. Pulmonary functions-FEF25-75

    Forced mid-expiratory flow (FEF25-75)

    Time frame: before the exercise training

  14. Pulmonary functions-FEF25-75

    Forced mid-expiratory flow (FEF25-75)

    Time frame: eigth week

  15. Peripheral muscle strength

    Peripheral muscle strength will be assessed using dynamometer

    Time frame: before the exercise training

  16. Peripheral muscle strength

    Peripheral muscle strength will be assessed using dynamometer

    Time frame: eigth week

  17. 1 minute sit to stand test (STS) repetitions

    number of sit to stand for one minute is recorded

    Time frame: before the exercise training

  18. 1 minute sit to stand test (STS) repetitions

    number of sit to stand for one minute is recorded

    Time frame: eight week

  19. posture

    Posture will be assessed using Corbin Postural Assessment scale. Lateral and posterior views will be assessed (0 = absent,1 = mild, 2 = moderate, 3 = severe) and posture score will be determined as excellent(0-2), very good (3-4), good (5-7), fair (8-11)and poor (\>12).

    Time frame: before the exercise training

  20. posture

    Posture will be assessed using Corbin Postural Assessment scale. Lateral and posterior views will be assessed (0 = absent,1 = mild, 2 = moderate, 3 = severe) and posture score will be determined as excellent(0-2), very good (3-4), good (5-7), fair (8-11)and poor (\>12).

    Time frame: eigth week

  21. Quality of life assessment

    Quality of life will be assessed using the Cystic Fibrosis Questionnaire-Revised .The Cystic Fibrosis Questionnaire-Revised is a disease-specific health-related quality of life measure for children, adolescents with cystic fibrosis (CF). The questionnaire evaluate physical functioning, emotional functioning, social functioning, body image, eating disorders, treatment,respiratory symptoms and digestive symptoms. Score range is 0-100. Higher scores indicating higher health-related qualityof life.

    Time frame: before the exercise training

  22. Quality of life assessment

    Quality of life will be assessed using the Cystic Fibrosis Questionnaire-Revised .The Cystic Fibrosis Questionnaire-Revised is a disease-specific health-related quality of life measure for children, adolescents with cystic fibrosis (CF). The questionnaire evaluate physical functioning, emotional functioning, social functioning, body image, eating disorders, treatment,respiratory symptoms and digestive symptoms. Score range is 0-100. Higher scores indicating higher health-related quality of life.

    Time frame: eigth week

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Jul 2027, 24 months after the start.

Of 214 non-industry interventional studies with no phase under Cystic Fibrosis, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 24 months is close to that.

Counting every sponsor, half of 229 studies reached it within 23 months; a quarter within 12 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 5, 2026
First posted
Nov 12, 2026
StartActual
Jul 10, 2025
Primary completionEst.
Jul 2027
CompletionEst.
Jul 2027
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07930221
Responsible party
Naciye Vardar-Yagli (PhD, Hacettepe University) — Principal investigator
First posted
Nov 12, 2026
Start date
Jul 10, 2025
Primary completion
Jul 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Nov 12, 2026

Study contacts

Naciye Vardar-Yagli, PhD
Contact
naciyevardar@yahoo.com
+903123051576 ext 129
Naciye Vardar-Yagli, PhD
principal investigator · Hacettepe University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion